Search This Blog

Monday, August 12, 2019

Kiniksa Pharmaceuticals EPS beats by $0.06

Kiniksa Pharmaceuticals (NASDAQ:KNSA): Q2 GAAP EPS of -$0.68 beats by $0.06.
Cash, cash equivalents and short-term investments of $287.4M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)